Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
2
29%
Ph phase_2
3
43%
Ph phase_1
2
29%

Phase Distribution

2

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 23 (42.9%)
Phase 32 (28.6%)

Trials by Status

completed571%
terminated114%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_2

Evaluation of Vepoloxamer in Chronic Heart Failure

NCT02596477
withdrawnphase_1

Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

NCT01407900
completedphase_2

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

NCT00612014
completedphase_2

Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery

NCT00617552
completedphase_3

Ulimorelin Study of Efficacy and Safety (ULISES 008)

NCT01296620
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02596477Phase 2

Evaluation of Vepoloxamer in Chronic Heart Failure

Terminated
NCT01407900Phase 1

Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

Withdrawn
NCT00612014Phase 2

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

Completed
NCT00617552Phase 2

Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery

Completed
NCT01296620Phase 3

Ulimorelin Study of Efficacy and Safety (ULISES 008)

Completed
NCT01285570Phase 3

Ulimorelin Study of Efficacy and Safety (ULISES 007)

Completed
NCT00639808Phase 1

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7